These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33428596)

  • 1. Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer.
    Huang Y; Wang X; Zheng Y; Chen W; Zheng Y; Li G; Lou W; Wang X
    Aging (Albany NY); 2021 Jan; 13(1):1153-1175. PubMed ID: 33428596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.
    Wang W; Lou W; Ding B; Yang B; Lu H; Kong Q; Fan W
    Aging (Albany NY); 2019 May; 11(9):2610-2627. PubMed ID: 31061236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer.
    Jia X; Shi Y; Zhu Y; Meng W; He L; Jia Y; Tong Z
    J Comput Biol; 2020 Jul; 27(7):1055-1066. PubMed ID: 31647320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
    Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
    Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of a competing endogenous RNA network reveals an 11-lncRNA prognostic signature in ovarian cancer.
    Zhang Y; Zhou H; Zhang M; Xing L; Yang C; Xia B; Lou G
    Aging (Albany NY); 2020 Nov; 12(24):25153-25171. PubMed ID: 33223503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and analysis of competitive endogenous RNA regulatory network related to gastric cancer].
    Li R; Jiang WJ; Jin SL; Zhao RH; Cao XG; Zong H
    Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):115-121. PubMed ID: 32135645
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer.
    Le K; Guo H; Zhang Q; Huang X; Xu M; Huang Z; Yi P
    Sci Rep; 2019 Oct; 9(1):15122. PubMed ID: 31641220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of dysregulated lncRNAs and their competing endogenous RNA network in triple-negative breast cancer.
    Naorem LD; Prakash VS; Muthaiyan M; Venkatesan A
    Int J Biol Macromol; 2020 Feb; 145():429-436. PubMed ID: 31883894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer.
    Yao Y; Zhang T; Qi L; Zhou C; Wei J; Feng F; Liu R; Sun C
    J Cell Mol Med; 2019 Dec; 23(12):8410-8419. PubMed ID: 31613058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening protective miRNAs and constructing novel lncRNAs/miRNAs/mRNAs networks and prognostic models for triple-negative breast cancer.
    Zhao Y; Song Y; Zhang Y; Ji M; Hou P; Sui F
    Mol Cell Probes; 2023 Dec; 72():101940. PubMed ID: 37871689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer.
    Ma J; Wang F; Chen C; Ji J; Huang P; Wei D; Zhang Y; Ren L
    Breast Cancer; 2023 May; 30(3):379-392. PubMed ID: 36622564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a Competitive Endogenous RNA Network in Uterine Corpus Endometrial Carcinoma.
    Ouyang D; Li R; Li Y; Zhu X
    Med Sci Monit; 2019 Oct; 25():7998-8010. PubMed ID: 31650984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel lncRNA-miRNA-mRNA competing endogenous RNA network associated with prognosis of breast cancer.
    Wan X; Hao S; Hu C; Qu R
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23089. PubMed ID: 35532246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
    Zhou D; Gao B; Yang Q; Kong Y; Wang W
    Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
    Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
    Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.